Background: Lifestyle factors play a pivotal role in the primary and tertiary prevention of colorectal cancer. The purpose of this review article is to summarize data concerning the effect of the lifestyle factors physical activity (PA) and nutrition in primary and, more importantly, tertiary prevention of colorectal cancer (CRC). Methods: Focusing on the influence of lifestyle factors on prognosis und quality of life (QOL), a comprehensive literature search of clinical studies published mainly in the years 2000 until 2015 was performed and the current knowledge based on these clinical studies reviewed. Results: Besides avoiding risk factors (such as smoking and overindulgence in alcohol), healthy weight, regular and moderate PA as well as a diet which contains fruit, vegetables, poultry, and fish (so-called ‘Mediterranean' diet) may reduce the risk of the disease significantly. Patients already diagnosed with CRC can also actively improve the prognosis of CRC and QOL by changing their lifestyle. Patients commencing moderate exercise and modifying their eating habits in terms of a ‘Mediterranean' diet can reduce cancer-specific and overall mortality by up to 40% and significantly increase their quality of life already during chemotherapy. Therefore, moderate physical exercise, calorie restriction, and a Mediterranean dietary pattern for patients with CRC should be recommended by physicians treating these patients. In fact, the World Cancer Research Fund/American Institute for Cancer Research (AICR/WCRF) systematic literature review from 2007 shows that the lifestyle changes recommended after diagnosis are the same for primary prevention of this disease. Conclusion: Lifestyle changes such as moderate PA and a Mediterranean diet significantly improve the QOL as well as the prognosis of patients suffering from colorectal disease. However, the effect of lifestyle changes is mostly based on observational studies, while only few studies are prospective and none are randomized. Therefore, these observational studies warrant controlled randomized trials to prove the effectiveness of lifestyle interventions on QOL and cancer recurrence.

Keywords:
Colorectal cancer, Physical activity, Mediterranean diet, Prognosis, Quality of life
1.
Washington MK: Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 2008;132:1600-1607.
2.
Wolin KY, Yan Y, Colditz GA, Lee IM: Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009;100:611-616.
3.
Chao A, Connell CJ, Jacobs EJ, McCullough ML, Patel AV, Calle EE, Cokkinides VE, Thun MJ: Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2004;13:2187-2195.
4.
Aleksandrova K, Pischon T, Jenab M, et al: Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med 2014;12:168.
5.
Boyle T, Keegel T, Bull F, Heyworth J, Fritschi L: Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 2012;104:1548-1561.
6.
Colbert LH, Hartman TJ, Malila N, Limburg PJ, Pietinen P, Virtamo J, Taylor PR, Albanes D: Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer Epidemiol Biomarkers Prev 2001;10:265-268.
7.
Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, Holubkov R, Schaffer D: Physical activity and colorectal cancer. Am J Epidemiol 2003;158:214-224.
8.
Steindorf K, Jedrychowski W, Schmidt M, Popiela T, Penar A, Galas A, Wahrendorf J: Case-control study of lifetime occupational and recreational physical activity and risks of colon and rectal cancer. Eur J Cancer Prev 2005;14:363-371.
9.
Courneya KS, Segal RJ, Mackey JR, et al: Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 2007;25:4396-4404.
10.
Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J: Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999;85:2273-2277.
11.
van Vulpen JK, Velthuis MJ, Steins Bisschop CN, et al: Effects of an exercise program in colon cancer patients undergoing chemotherapy. Med Sci Sports Exerc 2015;48:767-775.
12.
Haydon AM, Macinnis RJ, English DR, Giles GG: Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006;55:62-67.
13.
Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS: 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-1581.
14.
Ainsworth BE, Haskell WL, Whitt MC, et al: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32: S498-504.
15.
Meyerhardt JA, Heseltine D, Niedzwiecki D, et al: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006;24:3535-3541.
16.
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527-3534.
17.
Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS: Physical activity and male colorectal cancer survival. Arch Intern Med 2009;169:2102-2108.
18.
Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK: The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomarkers Prev 2011;20:1410-1420.
19.
Kuiper JG, Phipps AI, Neuhouser ML, et al: Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012;23:1939-1948.
20.
Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM: Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 2013;31:876-885.
21.
Schmid D, Leitzmann MF: Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 2014;25:1293-1311.
22.
Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Fairey AS: A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care (Engl) 2003;12:347-357.
23.
Pisani P: Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 2008;114:63-70.
24.
Inoue M, Tsugane S: Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer 2012;19: F1-8.
25.
Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, Turatti A, Garcia SB: Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis. Med Sci Sports Exerc 2008;40:618-621.
26.
Rigas B, Tsioulias GJ: The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism. J Pharmacol Exp Ther 2015;353:2-8.
27.
Yamauchi M, Lochhead P, Imamura Y, et al: Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013;22:1142-1152.
28.
Aoi W, Naito Y, Takagi T, et al: A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 2013;62:882-889.
29.
Wolin KY, Yan Y, Colditz GA: Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer 2011;104:882-885.
30.
Meyerhardt JA, Niedzwiecki D, Hollis D, et al: Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008;26:4109-4115.
31.
Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM: Impact of body mass index on survival after colorectal cancer diagnosis: The Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012;30:42-52.
32.
Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS: Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007;298:754-764.
33.
Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS: Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26:2984-2991.
34.
Cole BF, Baron JA, Sandler RS, et al: Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-2359.
35.
Gravitz L: Prevention: tending the gut. Nature 2015;521:S6-8.
36.
Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B: Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol 2015;54:5-16.
37.
Brenner H, Kloor M, Pox CP: Colorectal cancer. Lancet 2014;383:1490-1502.
38.
Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B: Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-96.
39.
Gaedcke J, Liersch T, Hess C, Becker H, Rodel C, Ghadimi BM: Rectal cancer: current status of multimodal therapy - when and how? (Article in German). Zentralbl Chir 2011;136:334-342.
40.
Orlich MJ, Singh PN, Sabate J, et al: Vegetarian dietary patterns and the risk of colorectal cancers. JAMA Intern Med 2015;175:767-776.
41.
World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC, AICR/WCRF, 2007. www.aicr.org/assets/docs/pdf/reports/Second_Expert_Report.pdf.
© 2016 S. Karger GmbH, Freiburg
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.